Home

About Diabetes

Complications

Warning Signs

Screening Test

Donate Now

E-Lerts™ Index

Latest News

Diabetes Terms

Health & Fitness

Online Press Center

Meet Mr. Diabetes^®

Wake Up And Walk^® Tour

Headlines & Stories

About Us - Contact Info

Message Board

Links

Chromium Picolinate Cleared Of Toxic Charges
posted September 22, 2004

The safety research overwhelmingly confirms that chromium picolinate is a safe nutritional supplement. Chromium picolinate received a further boost when the Society of Toxicology affirmed its safety as a nutritional supplement.

A review of recent studies on the safety of chromium picolinate was presented last week by Ronald Slesinski, the president-elect of the regulatory and safety specialty section of the society, at a Centers for Disease Control and Prevention (CDC) conference on metal toxicity and carcinogenesis.

"The safety research overwhelmingly confirms that Chromax chromium picolinate is a safe nutritional supplement," said Dr. Slesinski. "Research studies conducted by the United States Department of Agriculture (USDA), National Toxicology Program (NTP) and at independent testing laboratories, show no evidence of genetic toxicity."

Dr. Slesinski also addressed findings from two previous laboratory studies alleging adverse effects on hamster cells exposed to chromium picolinate.

"The new studies showed that comparative or higher doses of Chromax chromium picolinate produced no adverse effects in these same tests," said Dr. Slesinski. "Chromax chromium picolinate has never been shown to be mutagenic in animals or to produce damage to genetic material (DNA) in humans when ingested, at any dose."

Chromax chromium picolinate is manufactured by Nutrition 21, which has focused closely on the ability of this supplement to help diabetes' sufferers.

The company is currently carrying out several studies, including one looking at the effect of chromium picolinate on type two diabetes - the results of which are expected at the end of this year.

Nutrition 21 is presently awaiting a decision by the US government as to whether the FDA will award a health claim to chromium picolinate in the prevention of diabetes. This decision should be made sometime in November, but James Komorowski, vice president of scientific affairs and technical services, said that said that feedback from the public comment period had been favorable.

There are an estimated 18.2 million people in the United States who have diabetes, putting them at high risk of complications such as heart disease and stroke, blindness, nerve damage, kidney damage and foot complications resulting from poor blood flow

Source: Diabetes In Control.com.

September 2004 News Article Index